Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination

• Samantha F. Kornfeld ,

  Contributed equally to this work with: Samantha F. Kornfeld, Anisha Lynch-Godrei

  Affiliations Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada K1H 8L6, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5

  ⨯
• Anisha Lynch-Godrei ,

  Contributed equally to this work with: Samantha F. Kornfeld, Anisha Lynch-Godrei

  Affiliations Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada K1H 8L6, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5

  ⨯
• Sawyer R. Bonin,

  Affiliation Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada K1H 8L6

  ⨯
• Sabrina Gibeault,

  Affiliation Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada K1H 8L6

  ⨯
• Yves De Repentigny,

  Affiliation Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada K1H 8L6

  ⨯
• Rashmi Kothary

  * E-mail: rkothary@ohri.ca

  Affiliations Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada K1H 8L6, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5, University of Ottawa Centre for Neuromuscular Disease, Ottawa, Ontario, Canada K1H 8M5

  ⨯